The UK’s prevention agenda is accelerating – but will only succeed when diagnostics become more connected, more predictable and easier to access.
In a system grappling with workforce pressures, rising chronic disease and inequalities, early detection can no longer rely on fragmented workflows and disconnected systems.
It requires an end-to-end diagnostic infrastructure.
RDi combines clinically compliant kitting with their +CURA digital ecosystem to provide an end-to-end operational foundation for modern diagnostics, capable of supporting national screening, clinical pathways and population health and wellbeing at scale.
Infrastructure over intervention
RDi’s physical service matters just as much as the digital one.
Every step in the testing chain needs to be traceable and governed for earlier detection to work. As well as automated processes that allow scalability and speed.
We’ve already delivered over 130 million self-sampling kits, supporting NHS screening, clinical research, retail health and private providers. This scale demonstrates that prevention-focused diagnostics can reach people where they actually are, reducing barriers like travel, stigma and time.
This foundation is built on:
- User-centric, clinically compliant kit design
- Full logistics and traceability from test order to result
- Alignment with NHS digital and operational standards
For commissioners and clinical leaders, this shifts diagnostics from variable and labour-intensive to scalable and possible.
More about +CURA: our real-time, digital interoperable system for diagnostics
Built to integrate with existing LIMS/EHR and national systems, +CURA connects patients, couriers, labs and the NHS across remote and in-clinic testing, enabling:
- Digital test requests and sample registration
- Real-time status tracking for patients
- Demographic and engagement insights for clinicians
The result:
- Patients get transparency and reassurance
- Clinicians get more actionable visibility
- Systems gain the intelligence to optimise pathways continuously
This is the foundation for end-to-end diagnostics – where missed samples and bottlenecks are visible and fixable.
Designing end-to-end screening pathways
Efficient end-to-end pathways are the gold standard for population screening. RDi’s prostate screening model demonstrates this evolution:
- Clinically validated at-home sampling
- QR-guided workflows for patients
- Full LIMS integration
- Automated recall and referral triggers
- Real-time dashboards for population insight
The benefits for NHS Trust and ICBs are significant:
- No more untracked results
- Faster escalation
- More targeted outreach to high-risk groups
Whether it’s bowel cancer, HPV, metabolic screening or PSA, the same platform architecture applies – ready for national rollout.
Why RDi qualifies as a true diagnostic platform
Most suppliers offer individual components: kits or logistics or software or analytics.
RDi combines five pillars into one integrated platform:
- Kitting and manufacturing
- Regulatory and compliance infrastructure
- National-scale logistics and fulfilment
- Digital test tracking (+CURA)
- Interoperable data and diagnostic insights
This reduces complexity and gives health systems the ability to run prevention and diagnostic programmes with ease and confidence.
If you’re exploring how to modernise your diagnostic pathways, strengthen prevention programmes or build trusted screening infrastructure, we’d love to share more.
Speak to our team to see how we can support your clinical, digital or commissioning priorities.
